Uncover key drivers, emerging technologies, and competitive movements shaping the antibody discovery market from 2025–2034 with trusted insights from The Business Research Company
What Are The Market Size Estimates For The Antibody Discovery Market Now And By 2029?
The antibody discovery market size has seen significant expansion over recent years. It is projected to increase from $8.96 billion in 2024 to $9.78 billion in 2025, showing a compound annual growth rate (CAGR) of 9.2%. The historical growth within this market can be linked to a rise in investment dedicated to drug discovery, an increasing focus on research and development initiatives, and the widespread presence of various healthcare research centers and academic institutions.
The antibody discovery market is poised for robust expansion over the coming years. This market is projected to reach $14.31 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.0%. This anticipated growth is driven by factors such as the rising need for antibody drug discovery services and platforms, a significant increase in funding for new technological advancements, the escalating demand for precision therapeutics, and the expanded application of antibodies beyond their traditional therapeutic uses. Key trends anticipated during this period encompass heightened research and development endeavors, the increasing prevalence of monoclonal antibodies, wider integration of cutting-edge technologies, a rising need for targeted therapeutics, and the creation of innovative antibody formats.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp
Which Long-Term Drivers Are Expected To Sustain The Antibody Discovery Market?
The burgeoning demand for precision therapeutics is anticipated to fuel the expansion of the antibody discovery market in the coming years. Precision therapeutics, also known as personalized therapeutics, involves tailoring medical treatments and interventions to fit the distinct characteristics of each individual patient. Antibody discovery plays a crucial role in precision therapeutics by facilitating the creation of targeted therapies, such as monoclonal antibodies. These therapies are specifically engineered to interact with disease-related molecules or cells with high precision, leading to more effective and individualized treatment outcomes. For instance, data from January 2023, provided by the US-based professional membership organization, the Personalized Medicine Coalition, indicated that in 2022, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave approval to 37 new molecular entities (NMEs). Of the 35 therapeutic NMEs among these, approximately 34%, representing 12 entities, were designated as personalized medicines by the Personalized Medicine Coalition (PMC). Consequently, the increasing requirement for precision therapeutics is set to propel the growth of the antibody discovery market.
How Is The Antibody Discovery Market Classified By Different Segments?
The antibody discovery market covered in this report is segmented –
1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory
Subsegments:
1) By Phage Display: Selection And Screening Techniques, Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques
What Current And Upcoming Trends Are Shaping The Antibody Discovery Market?
Leading companies operating in the antibody discovery market are developing cutting-edge technologies, such as AI-driven computational platforms for antibody drug discovery, to enhance the effectiveness and precision of antibody development. An AI-powered computational antibody drug discovery platform utilizes artificial intelligence and computational methods to expedite the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company focused on producing recombinant proteins from a specialized plant-based system, introduced an AI-driven antibody discovery platform. This innovative tool integrates artificial intelligence, big data, machine learning, and phage display techniques to rapidly forecast antibody-antigen binding with high specificity and high affinity. This approach, akin to natural language processing, generates a diverse range of antibody variations, enabling SwiftPharma to efficiently establish comprehensive antibody libraries. This advanced system significantly accelerates the discovery of potential antibody drugs with unprecedented speed.
Who Are The Primary Market Leaders In The Antibody Discovery Market?
Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report
Which Regional Markets Are Emerging As Key Centers For The Antibody Discovery Market?
North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp
Browse Through More Reports Similar to the Global Antibody Discovery Market 2025, By The Business Research Company
Antibody Contract Manufacturing Global Market Report 2025
Next Generation Antibody Therapeutics Global Market Report 2025
Antibody Drug Conjugates Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
